Cochlear Diseases

Pathological processes of the snail-like structure (COCHLEA) of the inner ear (LABYRINTH) which can involve its nervous tissue, blood vessels, or fluid (ENDOLYMPH).

Also Known As:

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Facioscapulohumeral Muscular Dystrophy
2.	Wounds and Injuries (Trauma)
3.	Inflammation

Experts

1.	Kil, Sung-Hee: 1 article (04/2015)
2.	Oh, Sejo: 1 article (04/2015)
3.	Lee, Yoo-Jin: 1 article (04/2015)
4.	Lim, David J: 1 article (04/2015)
5.	Moon, Sung K: 1 article (04/2015)
6.	Park, Raekil: 1 article (04/2015)
7.	Woo, Jeong-Im: 1 article (04/2015)
8.	Narumiya, Shuh: 1 article (03/2012)
9.	Hamaguchi, Kiyomi: 1 article (03/2012)
10.	Nakagawa, Takayuki: 1 article (03/2012)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Cochlear Diseases:

1.	Interleukin-1beta (Interleukin 1 beta)IBA 09/01/2002 - "Interleukin-1beta expression is a general cochlear response to trauma, whereas tumor necrosis factor-alpha expression in the infiltrated immunocompetent cells is the cytokine that induces amplification of the response that leads to cochlear disease."
2.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/01/2002 - "Interleukin-1beta expression is a general cochlear response to trauma, whereas tumor necrosis factor-alpha expression in the infiltrated immunocompetent cells is the cytokine that induces amplification of the response that leads to cochlear disease."
3.	Retinaldehyde (Retinal)IBA 10/01/1999 - "Yet remarkably, the nature of the gene product(s) of the affected proximal gene(s), as well as of the molecular pathogenesis of facioscapulohumeral muscular dystrophy muscle, retinal and cochlear disease, is completely unknown. "
4.	Carbon MonoxideIBA 04/15/2015 - "Taken together, our results suggest that IL-10/HMOX1 signaling is involved in modulation of cochlear inflammation through inhibition of MCP-1/CCL2 regulation in SLFs, implying a therapeutic potential for a CO-based approach for inflammation-associated cochlear diseases. "

Therapies and Procedures

1.	Therapeutics 03/01/2012 - "EP4 might therefore be an effective target for cochlear disease therapeutics."
2.	Hearing Aids (Hearing Aid) 02/01/1994 - "This article will describe a clinical procedure using simultaneous pure-tone masking to improve upon the localization of cochlear disease, particularly for low-frequency hearing losses, and a model for using the Articulation Index (AI) to develop prognoses for hearing aid performance in these cases, which can then be tested. "